Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Your healthcare provider should evaluate your full medical history, current medications, and metabolic markers before recommending either agent
Increased GST and/or GT tumor expression, generally considered as a bad prognosis marker (associated with drug resistance and disease progression), and could potentially be used as a predictive marker, allowing doctors, after biopsy, to identify which patients will respond best to GST or GT-activated prodrugs
at their facilities
Deficient IGF- 1 input to vascular endothelial cells leads to impaired vasodilation, microvascular rarefaction, and reduced muscle endurance, without significant muscle atrophy
US$ 27.87
US$ 27.29
US$ 26.41
US$ 29.10
US$ 21.09
US$ 21.84
US$ 29.80
US$ 23.41
US$ 20.48
US$ 26.93
